ArticleContemporary oncology (Poznan, Poland)2017

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

Piotr Rutkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.